TY  - JOUR 
AU  - Escribano-Lopez, Irene
AU  - Díaz Morales, Noelia
AU  - Iannantuoni, Francesca
AU  - Lopez-Domenech, Sandra
AU  - de Marañon, Aranzazu M
AU  - Abad-Jimenez, Zaida
AU  - Bañuls, Celia
AU  - Rovira-Llopis, Susana
AU  - Herance, Jose R
AU  - Rocha, Milagros
AU  - Victor, Victor M
PY  - 2018
UR  - http://hdl.handle.net/10366/169700
AB  - [EN]There is growing focus on mitochondrial impairment and cardiovascular diseases (CVD) in type 2 diabetes (T2D), and the development of novel therapeutic strategies in this context. It is unknown whether mitochondrial-targeting antioxidants such as...
LA  - spa
PB  - Nature Research (Springer Nature)
KW  - Sirtuina 1 (SIRT1)
KW  - Diabetes tipo 2
KW  - Antioxidante mitocondrial (SS-31)
KW  - Interacción leucocito-endotelio
KW  - Estrés oxidativo
KW  - Inflamación
KW  - Sirtuin 1 (SIRT1)
KW  - Type 2 diabetes
KW  - Mitochondrial antioxidant (SS-31)
KW  - Leukocyte-endothelium interaction
KW  - Oxidative stress
KW  - Inflammation
KW  - Diabetes Mellitus, Type 2
KW  - Antioxidants
KW  - Oxidative Stress
KW  - Sirtuin 1
KW  - Mitochondria
TI  - The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
DO  - 10.1038/s41598-018-34251-8
T2  - Scientific Reports
VL  - 8
ER  -